GOLPH3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.448200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.286200E-01
Normal-vs-Stage2
8.151800E-01
Normal-vs-Stage3
4.386000E-01
Normal-vs-Stage4
4.562800E-01
Stage1-vs-Stage2
9.489000E-01
Stage1-vs-Stage3
2.628600E-01
Stage1-vs-Stage4
4.718400E-01
Stage2-vs-Stage3
1.476230E-01
Stage2-vs-Stage4
2.658600E-01
Stage3-vs-Stage4
1.349400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.118600E-01
Normal-vs-AfricanAmerican
4.009200E-01
Normal-vs-Asian
7.245800E-01
Caucasian-vs-AfricanAmerican
6.832100E-02
Caucasian-vs-Asian
5.650800E-01
AfricanAmerican-vs-Asian
5.218200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.876600E-01
Normal-vs-Female
7.876600E-01
Male-vs-Female
6.351800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.646600E-01
Normal-vs-Age(41-60Yrs)
4.347800E-01
Normal-vs-Age(61-80Yrs)
9.735000E-01
Normal-vs-Age(81-100Yrs)
5.108600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.712210E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.561800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.820000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.072100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.740300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.564170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.021200E-01
Normal-vs-Daily Drinker
6.174400E-01
Normal-vs-Weekly Drinker
7.521200E-01
Normal-vs-Occasional Drinker
6.232200E-01
Normal-vs-Social Drinker
6.096600E-01
Non Drinker-vs-Daily Drinker
4.902800E-01
Non Drinker-vs-Weekly Drinker
2.657600E-01
Non Drinker-vs-Occasional Drinker
1.134370E-01
Non Drinker-vs-Social Drinker
1.166220E-01
Daily Drinker-vs-Weekly Drinker
1.394610E-01
Daily Drinker-vs-Occasional Drinker
5.759900E-02
Daily Drinker-vs-Social Drinker
6.426400E-02
Weekly Drinker-vs-Occasional Drinker
7.257800E-01
Weekly Drinker-vs-Social Drinker
6.888000E-01
Occasional Drinker-vs-Social Drinker
9.447800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.100800E-01
Normal-vs-Grade 2
7.335400E-01
Normal-vs-Grade 3
7.472400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.809000E-01
Grade 1-vs-Grade 3
7.532400E-01
Grade 1-vs-Grade 4
4.100800E-01
Grade 2-vs-Grade 3
7.471400E-01
Grade 2-vs-Grade 4
7.335400E-01
Grade 3-vs-Grade 4
7.472400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.950800E-01
Normal-vs-NonDiabetic
8.727200E-01
Diabetic-vs-NonDiabetic
1.752170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.715200E-01
Normal-vs-NoPancreatitis
9.236600E-01
Pancreatitis-vs-NoPancreatitis
8.030800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.566800E-01
Normal-vs-N1
8.237800E-01
N0-vs-N1
9.129400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.126000E-01
Normal-vs-TP53-NonMutant
6.241800E-01
TP53-Mutant-vs-TP53-NonMutant
9.549000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
